HOUSTON, Texas--Head of the Cancer Imaging Department at British Columbia Cancer Research Center, Dr. Calum MacAulay has created an online one-hour continuing education course on Trimira LLC's Identafi 3000 ultra.
The course, titled "Tissue Autofluorescence as An Aid in the Detection of Early Cancer and At-Risk Tissue," is offered through a partnership between BCCRC, an arm of the British Columbia Cancer Agency, and Trimira LLC.
The Identafi 3000 ultra is an oral cancer screening device that uses a triple-wavelength fluorescence and reflectance optical system for early detection.
MacAulay's work focuses on research and development of new means for the detection, grading, and treatment of early, noninvasive cancer. He has helped develop devices that employ solid state sensors and advanced light sources, coupled with computer technology, to make previously invisible early cancers readily detectable.
Targeting dentists, periodontists, oral surgeons, primary-care physicians, and otolaryngologists, the electronic course is accredited by Health Science. The course instructs users in how to optimize Identafi® 3000 ultra's brilliant white, violet, and green-amber illumination.
Created exclusively for intraoral use, the cordless Identafi® 3000 ultra is lightweight, portable, and ergonomically shaped. It incorporates a nickel-plated design that improves durability and delivers a smoother feel. The handheld is portable, and thus is readily moved from room to room and patient to patient.
Trimira is a privately held, Houston-based, medical diagnostic and imaging device company that has patented several cancer detection technologies. Included is "multispectral" technology, which minimizes false positives in oral tissue and reveals abnormalities missed by the naked eye.
Visit Trimira at Trimira.
To read more about cancer screenings, go to cancer screenings.
To comment on this topic, go to PennWell Dental Community site.
